Kara Egan
Showing 1–1 of 1 transcripts.
- Milken Institute1h 1m
The Cancer Diagnostics Revolution | Global Conference 2024
Gregory Simon, Kara Egan, Helmy Eltoukhy, Jody Hoyos, Larry Kessler, Anaeze Offodile, Greg Simon
Experts and industry leaders convened to discuss the technological evolution of liquid biopsies for early-stage, pan-cancer detection while addressing critical barriers regarding clinical efficacy, health equity, and reimbursement. The dialogue highlighted the necessity of randomized control trials to prove mortality benefits over simple downstaging, noting that false positives can trigger invasive diagnostic odysseys without extending life. Panelists from organizations like GARDEN and Teal Health outlined specific strategic goals, including securing Medicare coverage and developing at-home screening devices to reduce the 25% of women currently behind on recommended cancer screenings.